The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 23,400 shares, a growth of 216.2% from the December 31st total of 7,400 shares. Based on an average trading volume of 28,300 shares, the short-interest ratio is presently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Price Performance

Shares of CGABL stock opened at $18.96 on Friday. The company’s fifty day simple moving average is $18.55 and its 200-day simple moving average is $19.15. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52 week low of $17.48 and a 52 week high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, February 15th. Shareholders of record on Saturday, February 1st will be given a $0.2891 dividend. The ex-dividend date is Friday, January 31st. This is a positive change from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 annualized dividend and a yield of 6.10%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.